These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8354911

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
    Viviani MA, Tortorano AM, Malaspina C, Colledan M, Paone G, Rossi G, Bordone G, Pagano A.
    Eur J Epidemiol; 1992 May; 8(3):433-6. PubMed ID: 1397207
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
    Diamond DM, Bauer M, Daniel BE, Leal MA, Johnson D, Williams BK, Thomas AM, Ding JC, Najvar L, Graybill JR, Larsen RA.
    Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
    Atkinson BA, Bouthet C, Bocanegra R, Correa A, Luther MF, Graybill JR.
    J Antimicrob Chemother; 1995 May; 35(5):631-40. PubMed ID: 7592176
    [Abstract] [Full Text] [Related]

  • 29. [Progress in combination therapy for invasive aspergillosis].
    Luo L, Tong Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Saperconazole therapy in a rabbit model of invasive aspergillosis.
    Patterson TF, George D, Miniter P, Andriole VT.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2681-5. PubMed ID: 1482137
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS.
    Lancet; 2004 May 29; 363(9423):1764-7. PubMed ID: 15172774
    [Abstract] [Full Text] [Related]

  • 35. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A.
    Chemotherapy; 1987 May 29; 33(5):381-95. PubMed ID: 2822362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
    Anndo T.
    Jpn J Antibiot; 2000 Feb 29; 53(2):84-90; dicussion 90. PubMed ID: 10896540
    [No Abstract] [Full Text] [Related]

  • 40. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR, Connolly PA, Durkin MM, LeMonte AM, Smedema ML, Brizendine E, Wheat LJ.
    J Infect Dis; 2002 Jun 15; 185(12):1830-2. PubMed ID: 12085335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.